If you’re looking for MS care in New Jersey, you have a range of specialized centers across the state — from AMG Multiple Sclerosis Comprehensive Care Center to Cooper Neurological Institute and Hackensack UMC Multiple Sclerosis Center. Use this page to compare services, locations, and provider experience so you can pick the center that best fits your needs.
11 MS treatment centers in New Jersey21 active clinical trials2 providers with Medicare prescribing dataMajor regional centers: AMG, Cooper, Hackensack UMC
Center types in New Jersey
Dedicated MS Practice (5)
Academic MS Center (4)
Community Hospital Program (1)
Regional Neurology Group (1)
Filter by type:
45% of MS centers in New Jersey are classified as Dedicated MS Practice facilities.
Centers with Most Active Trials in New Jersey
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
Largest Care Teams in New Jersey
MS Care by City
Active MS clinical trials in New Jersey
See all 30 MS trials in New Jersey →ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Livingston · Neptune City
ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Neptune City
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Hackensack · Livingston · +3
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Hackensack
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Neptune City
ActivePhase 3
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
TG Therapeutics, Inc.
Teaneck
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Teaneck
ActivePhase 3
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
Newark · Teaneck








